Preparation of the Second Component of Human
Complement.--Approximately 800 ml of fresh serum was dialyzed for 48 hr against 3 X 10 liters of a 0.008 M solution of Na 3EDTA of pH 5.4 and a conductance of 1.25 millimhos per can. The pseudoglobulin fraction thus obtained was separated from the euglobulin fraction by centrifugafion and dialyzed overnight against phosphate buffer, pH 6.0, T/2 = 0.06, containing 0.002 M EDTA. This buffer, having a conductance of 4.0 millimhos per cm, will hereafter be referred to as "starting buffer." The dialyzed pseudoglobulin was then incubated at 37°C for 1 hr with dh'sopropyl fluorophosphate (DFP) at a final concentration of 10 -am to inactivate an enzyme which, like C'I esterase, has the ability to inactivate C'2 (and CP4) and which may, in fact, be identical with C'I esterase. This enzyme was shown to be present in C'2-containing fractions obtained from carboxymethyl (CM) cellulose chromatography, and had previously been responsible for substantial inactivation of C'2 during early stages of its purification. The DFP-treated pseudoglobulln was then applied to a 7.5 )< 60 cm column containing 2000 ml of packed CM cellulose, previously equilibrated with starting buffer. Mter the application of the sample, 10 liters of starting buffer was passed through the column; this process removed approximately 95% of the protein. C'2 was then eluted by the application of a gradient to 0.7 ~t NaC1 in starting buffer. The fractions containing C'2 activity were pooled, dialyzed overnight against starting buffer, and resubjected to chromatography on CM cellulose under conditions similar to those used for the first chromatographic step, the only difference being that a 4.5 X 60 cm column was employed. This step resulted in a 4-fold purification and a 2-fold concentration of the material. The fractions containing C'2 activity were pooled and concentrated to approximately 8 ml. This sample, following further incubation with DFP, was subjected to preparative electrophoresis for 24 hr on a Pevikon block at 4°C in phosphate buffer, pH 6.0, T/2 -~ 0.05, containing 0.0025 ~ EDTA, and employing a potential gradient of 3.5 v/cm. The fractions containing C'2 activity were pooled and concentrated to approximately 5 ml. The C'2 at this stage in the isolation procedure had undergone an approximate 1800-fold purification in terms of protein, the recovery of C'2 hemolytic activity as determined by effective molecule titration (8) being approximately 30%. As a final step in the isolation procedure, this material was subjected to chromatography on OH-apatite, a step which will be described in detail elsewhere, x Throughout the present work, the preparation of Cr2, concentrated following elution from the Pevikon block, was used as the source of C'2. The protein concentration was 1-1.5 mg/ml.
Preparation of the Third and Fourth Components of Human
Complement.--C'3 and C'4 were isolated according to the method previously described (9, 10) .
Preparation of EAC'la, 4 Complex. 10 ml of a 2.5% suspension of sheep red cells sensitized with rabbit anti-sheep red cell antibody (EA) were incubated at 37°C for 15 rain with 0.2 ml of each C'lq, C'lr, and C'ls, and 0.6 ml of saline containing 5.4 X 10-a ~ Ca ++ and 1.975 )< 10 -2 ~ Mg ++. 100 #g of purified C'4 was added and incubation continued for a further 15 rain. The cells were washed twice with veronal buffered saline containing 1.5 X 10-4 M Ca++ and 4.8 X 10 --4 ~ Mg ++, and then resuspended in the same buffer to their original volume, and in this state were referred to as EAC'la,4.
Assays for C'2 Hemolytic Activity.--One procedure for the determination of C'2 activity was performed utilizing a serum reagent lacking C'2 (R~) (11) .
To determine C'2 activity more precisely, EAC'la,4 cells were prepared as described above and the time of maximal formation of EAC'la,4,2 a (tm~x) at 32°C was determined both for untreated C'2 and iodine-treated C'2 (see below). 0.4 ml of EAC'la,4 was incubated at 32°C with various amounts of C~2 mixed with an equal volume of the saline containing Ca ++ and 1 Polley, M. J., and H. J. Mfiller-Eberhard. 1967. Isolation of the second component of complement (C'2) from human serum. In preparation.
Mg ++ ions. The total reaction volume was adjusted to 0.8 ml with veronal-NaC1 buffer. At tm~, C'EDTA (0.1 ml freshb,,mAu serum +0.1 m] 0.2 M EDTA) was added to supply the six subsequent complement components and incubation was allowed to proceed for 30 min. The tubes were then transferred to an ice bath and 2 ml ice-cold normal saline was added to stop the reaction. The tubes were immediately centrifuged at 0°C and the supernatants were removed for spectrophotometric assay of the hemoglobin.
Kinetic Analysis of the Formation and Decay of EAC'la,4,2a.--To 6 ml of a 2.5% suspension of EAC'la,4, prewarmed to 32°C, was added 1 ml of a suitable amount of purified C'2, in which the chelating activity of the EDTA had been overcome by the addition of an appropriate amount of the solution containing free Ca ++ and Mg ++ ions. After thorough mixing, 0.6 ml aliquots were removed at intervals of time and transferred to a tube containing a mixture of 0.1 ml fresh human serum -t-0.i ml 0.2 M EDTA previously warmed to 32°C. After incubation for 30 rain at 32°C, the tubes were transferred to an ice bath and processed as outlined above.
Preparation of tke Fluid Phase Complex, (C'4i,2)a (C'3 Convertase
).--This complex was prepared as described previously (1) utilizing for each preparation 200 ~tg of C'4 and amounts of C'2 varying between 1 and 100 pg. The reaction between C'I esterase, C'4 and C'2 was allowed to proceed for 2 rain at 32°C and then the material was stored at 0°C.
Treatment of (C'4i,2)a with Iodine.--Preparations of the complex were first treated with DFP at a final concentration of 5 X 10 -3 M for 60 rain at 0°C to inactivate C'1 esterase. This measure prevented formation of additional (C'4i,2)a from residual C'2 and C'4 subsequent to iodine treatment of the reaction mixture.
Each preparation of the complex was then divided into two equal parts, one of which was treated with an amount of iodine proportional to the quantity of C'2 used in its preparation; the complex prepared with 100/Lg of C'2 was treated with iodine at a final concentration of 1.25 X 10 ~ M in a 50-fold molar excess of KI. This reaction was allowed to proceed at 0°C for 15 rain, after which time no free iodine was demonstrable by potassium iodide starch paper. The second part was not treated with iodine and served as the control.
C'3 Conversion, Its Detection and Quantitation.--lO0/~g of purified C'3 was added to each preparation of the complex. Following a 30 rain period of incubation at 37°C, the conversion of C'3 to C'3i was stopped by cooling the reaction mixtures to 0°C. The degree of conversion was tested by immunoeleetrophoresis and quantitated using radioactively labeled C'3 as described earlier (12) .
Treatment of C'2 with Ckemical
Reagents.--One volume of the C'2 preparation was mixed with an equal volume of various concentrations of each reagent tested. The concentrations of the reagents ranged from 10-to 1,000-fold molar excess over the C'2 concentration. The reactions were allowed to proceed for 30 rain at 4°C and were then terminated by dilution, dialysis, or passage through Sephadex.
RESULTS

Effect of Various Sulfkydryl
Reagents on the Activity of C'2.--Since some degree of inactivation of C'2 encountered during its isolation procedure was prevented by the presence of EDTA, it was thought that the activity of C'2 might depend on a reactive sulfhydryl group within the molecule. This was particularly likely in view of Leon's observation that C'2 is inactivated by p-hydroxymercuribenzoate (13) . In addition, it was found in this laboratory that treatment of C'2 with p-chloromercuribenzoate (p-CMB) and iodoaeetic acid reduced the hemolytic activity to 10 %, and with cyanogen bromide and N-ethylmaleimide to 60 and 80%, respectively. 2-Mercaptoethanol, dithiothreitol, cysteine, and glu-tathione at concentrations greater than 10 -8 ~t also caused substantial reduction of C'2 hemolytic activity. By contrast, treatment with iodoacetamide resulted in marked enhancement of CI2 activity. Further analysis of this phenomenon showed that iodoacetamide produced no such enhancement when used immediately following recrystallization. However, the ability to enhance the activity reappeared slowly on storage. It was, therefore, suspected that the enhancement was due to contaminating free iodine and not to iodoacetamide per se. This was, indeed, shown to be the case (Table I) . Fig. 1 shows the effect of various concentrations of iodine at pH 6 on the hemolytic activity of Ct2. As C'2 was found to be most stable at pH 6 and enhancement to be maximal at 2.5 X 10 -5 ~ 12 at pH 6, the following method was selected for iodine treatment of C'2. One volume of the C'2 preparation (approximately 1 mg/ml) was mixed with an equal volume of phosphate buffer, pH 6.0, T/2 = 0.1, containing 5 X 10-~ ~r I~ and 2.5 × 10-3 ~t potassium iodide. The reaction mixture was kept for 5 rain at room temperature before it was chilled to 0°C and suitably diluted for further use. The C'2 so treated will be referred to as °xyC'2.
Effect of Iodine Treatment of C'2 Hemolytic Activi~y.--
It was possible under these conditions to achieve a marked enhancement of the hemolytic activity of C'2, Fig. 2 shows the results of a typical experiment to determine the dose response of unmodified C'2 and °xyC'2. y = per cent lysis and the negative logarithm of unlysed cells [--ln(1--y)] equals the average number of CI2a sites per cell (8) . In the experiment depicted in Fig. 2 , an average number of one site per cell was produced, when the relative concentration of unmodified C'2 was 8.15 and that of °~C'2, 0.5. The factor of enhancement was therefore 16.3. A similar degree of enhancement was obtained when the results were plotted according to the logarithmic transformation of the yon Krogh equation (Fig. 3) . The dose of untreated C'2 required for 50 % hemolysis i 80. °xyCt2 had a marked effect on the half-life of EAC'la,4,2a. Whereas the halflife of this complex at 32°C was 9 min when prepared with unmodified C'2, it increased to approximately 150 min when °xyCt2 was employed (Fig. 4) . Further, EAC'la,4,°xy2a cells were found to be stable for several days when stored at 0°C. It was apparent from these results that the ~,~ was always increased to some extent when °xyC'2 was employed. Whereas the lm,~ utilizing unmodified C'2 varied only between 3 and 5 min, variations between 5 and 15 min were obtained with °xyC'2. Since tr.,x varies with the number of C'la,4 sites per cell (8), a possible interpretation was that the iodine was, in fact, modifying the EAC'la,4 cells. This was not the case, however, since iodine under the same conditions used for treating C'2 had no effect on EAC'la,4, as meassured by t~,~. Furthermore, iodine treatment had no effect on either free solution or cell-bound C'4.
Another possible explanation for the observed enhancement was that iodine might reverse inactivation which had occurred during the process of isolation of Ct2. That this was not the case is demonstrated in Fig. 1 . Even fresh human serum exhibited a marked increase in C~2 hemolytic activity following treatment with iodine. Fresh guinea pig serum, however, exhibited no increase in C'2 hemolytic activity when tested under similar conditions. Similarly, no tested at the same concentration as that used for the chemically modified C'2 and at six times this concentration, tm~ for untreated C'2 was 3 rain, 5 rain for iodine-treated C'2, and 8 rain for iodoacetamide-treated Ct2. increase in hemolytic activity was observed when whole sera from monkey, horse, and cow were tested following treatment with iodine. ,2) a.--An experiment to determine the effect of chemical modification of bound C'2 by treatment of EAC~la,4,2a with iodine was not technically feasible, since iodine at the concentrations required produced lysis of the red cells. Therefore, the fluid phase (C'4i,2)a complex was utiliTed for this purpose. As shown in Table II , iodine treatment of preformed (C~4i,2)a caused an increase in the activity of this complex as measured by conversion of Ct3.90 % conversion was achieved with untreated C'3 convertase prepared with 100 ~g of CP2. A similar degree of conversion was observed with iodine-treated enzyme which was prepared with only 10 ~g of C'2.
E~ect of Iodine Treatment on (C'4i
Effect of Sequential Treatment of C'2 with Sulfhydryl-Blocking Reagents and
Iodine.-- Table III shows the effects of treatment with iodine, p-CMB, and recrystallized iodoacetamide either singly or sequentially on the hemolytic activity of C'2. Recrystallized iodoacetamide has virtually no effect, nor does it prevent enhancement by iodine or inactivation by p-CMB. The finding
TABLE II Effect of Iodine Treatment of (C'4i, 2)a on the C'3 Converting Activity of the Complex
Amount of C'2 used in preparation of (C'4i,2)a that treatment with iodine prevented subsequent inactivation by p-CMB suggested that both reagents affect and compete for the same critical group in C'2. However, treatment with p-CMB did not prevent subsequent enhancement by iodine. The latter observation appeared to contradict the above advanced hypothesis, unless under the conditions employed, the iodine was capable of removing the p-CMB. To find out whether it is principally possible to remove p-CMB from a sulfhydryl (-SH)-containing protein by treatment with iodine, experiments were performed using purified C'3, since this protein is more readily available in larger quantities and has been shown to contain two free sulfhydryl groups. * Using identical conditions, C~3 was treated with ~4C-labeled p-CMB. Mter thorough dialysis, it was determined that 2 moles of p-CMB were bound per mole of protein. Subsequent treatment with iodine resulted in total release of the previously bound ~4C label (Table IV) . Since in p-CMB the ~4C label is incorporated into the benzene ring, the most likely
TABLE IV
Tke Effect of Iodine Treatment on C'3 Pre~ou~ly Treated witk l*C-p-Ckloromercuriben~oate
Treatment Counts* per minute per 500 tzg C'3 14C-p-CMB 23,700 14C-p-CMB; iodine 240 1 mg C'3 was treated with 10 -a u uC-p-CMB for 2 hr at 0°C. Following extensive dialysis, the material was divided into two equal portions, one of which was treated with 10 "~ M I2 in 5 X 10-' M KI for 5 rain at room temperature. Both aliquots were then subjected to further dialysis.
* Counts were corrected for quenching and efficiency of counting by the liquid scintillation counter. interpretation of the total removal of counts by the iodine treatment is that under the conditions used the p-CMB was removed from the Cr3 molecules.
TABLE V
Iodine-Induced Enhancement of C'2 Hemolytic Activity Compared with Uptake of Iodine
The Nature of the Effect of Iodine Causing Enhancement of C~2 Activity.--The
results presented above suggested that the iodine effect on C'2 activity was due to the reaction of iodine with a sulfhydryl group in the C'2 molecule. Further evidence in support of this view was obtained through 126I-uptake studies. C'2 was treated with usI at three different pH's and uptake of iodine was compared with enhancement of activity. Table V shows that whereas enhancement of activity was pH dependent, being maximal at pH 6, uptakeof 126Iwas no greater at pH 6 than at the other two pH values. Conditions for the uptake experiment were such that for every 2 moles of radioactive iodine, 104 moles Polley, 2¢i. J., and H. J. Mtilier-Eberhard. Unpublished observations. unlabeled iodide and 103 moles unlabeled iodine were present. Provided that no protein in the preparation was labeled preferentially under these conditions and assuming a molecular weight of 115,000 for C'2 (1), it was calculated that at maximal enhancement of C~2 hemolytic activity, one mole of C'2 had bound less than 0.05 mole of iodine. It was, therefore, concluded that the iodine effect was not due to uptake of iodine, but to oxidation of some group in the C'2 molecule. Further proof for oxidation as opposed to iodination was obtained through the observation that the reducing agent, sodium dithionite, reversed the iodine effect and lowered the activity of treated C'2 to the original level or even below that of untreated Cr2. Moreover, subsequent treatment with iodine resulted in renewed enhancement of activity (Table VI) .
TABLE VI
Effect of Sequential Treatment with Iodine and the Reducing Agent Sodium Dithionite on the Hemolytic Activity of Cr2
Chemical reagent Hemolytic activity (% of untreated C'2) Iodine -- --225  Iodine  Iodine  --6  Iodine  Sodium dithionite  --20  Iodine  Sodium dithionite  Iodine  230 --, no further treatment.
DISCUSSION
Treatment of CP2 with a critical concentration of iodine has been shown to result in a more than 10-fold enhancement of its hemolytic activity and in the stabilization of the intermediate complex EACtla,4,2a prepared utilizing the chemically modified C'2. The precise nature of the induced chemical change and of the groups affected has not been defined. However, it was possible to eliminate certain explanations of the effect in preference to others. Thus, the principal reaction involved in iodine treatment of proteins is substitution into the tyrosyl residues resulting in the production of the monoiodo-or diiodotyrosyl derivative of the protein (14) . In the present study, under conditions favoring maximal enhancement of the hemolytic activity of Cr2, 0.05 mole of iodine was bound per mole of protein. Substitution into the tyrosyl residues as the cause for enhancement of Cr2 activity therefore seemed very unlikely. For the same reason, substitution into the imidazole ring of histidine appeared an equally unlikely explanation. Further evidence against histidine substitution being responsible for the iodine effect is the speed with which the enhancement became apparent. Whereas iodine substitution into histidine is a time dependent mechanism (14) , the effect of iodine on C~2 is apparently instan-taneons. By a process of elimination, therefore, oxidation of Ct2 was considered to be the most probable interpretation of the mechanism of enhancement. Since sulfhydryls are the most susceptible groups in proteins to oxidation by iodine, it is postulated that it is this type of group that is primarily involved in the observed activity change, although oxidation of a functionally relevant carbohydrate group has not been ruled out.
The oxidation of a sulfhydryl group takes place by two main routes. Mild oxidation of simple thiols results in the formation of disulfides. When strong oxidizing agents are employed, the reaction can proceed via sulfenic (-SOH) through sulfinic (-SO,H) to the sulfonic acid stage (-SO,H). The actual mechanism of the reaction and the intermediates involved are dependent on the conditions employed (13) . Two sulfhydryls can be oxidized to form a disulfide provided they are not sterically hindered in doing so (16) . In a protein molecule with relatively few -SH groups present, it may be impossible for any two of them to form a disulfide bond. Such an example is provided by/3-1actoglobulin. Treatment with iodine results in conversion of its two -SH groups to sulfenyl iodide and even in the presence of strong oxidizing agents these groups fail to form a disulfide bond. The behavior of the sulfhydryl groups in ovalbumin is even more complex. Of the four -SH groups present in the native protein, only three are reactive towards iodine. These are oxidized to sulfenyl iodides possessing varying degrees of stability, one being almost instantaneously decomposed to sulfenic acid, while the other two remain stable for several days (17) .
Since the poor uptake of iodine by C~2 indicates lack of substitution, formation of a sulfenyl iodide can also be excluded. Disulfide bond formation appears to be precluded by the finding that the iodine effect is reversible by treatment with Nw2S20,, a reducing agent which is not known to split disulfide bonds. However, oxidation of a disulfide bond by iodine with the resulting formation of two sulfonic acid derivatives (1S) cannot be excluded at present as a possible mechanism of enhancement. Nevertheless, the most likely interpretation is that the reaction of C'2 with iodine results in oxidation of one or more sulfhydryl groups to one of the sulfonic acid derivatives. Whether it be the sulfenic, sulflnic, or sulfonic form remains to be determined. Reversal of the iodine effect by the reducing agent sodium dithionite lends further support to this view.
Sequential treatment of C"2 with iodine and sulfhydryl reagents led to the apparently contradictory observations that whereas prior treatment with iodine prevented subsequent inactivation by p-CMB, prior treatment with p-CMB did not prevent subsequent enhancement by iodine. These findings were compatible only if iodine under the conditions employed could remove p-CMB from the critical sulfhydryl group. That this interpretation was indeed likely was shown by the finding that treatment with iodine under identical conditions to those used with C'2 totally removed the 14C label from C'3 previously substituted with 14C-p-CMB.
Enhancement of the activity of an enzyme by treatment with iodine is not unique. A 5-fold increase in the esterase activity of carboxypeptidase A followLug treatment with iodine has been reported (18) . However, in this case the iodine-induced enhancement was shown to be the result of iodine substitution into two reactive tyrosyl residues closely associated with the active center of the enzyme (19) .
In the present communication, data are presented describing the iodineinduced enhancement of another enzyme: CP3 convertase. This enzyme, which occurs in free solution and in cell-bound form, has recently been shown to be composed of two subunits, one derived from CP2 and the other from C'4 (1). In contrast to carboxypeptidase A, the effect of iodine on C'3 convertase appears to be due to oxidation of one or more critical sulfhydryl groups. The accumulated evidence indicates that the increase in activity and stability of the enzyme results solely from the modification of its C'2 subunit. The critical modification can be affected by treating native C'2 before it enters into the complex with CI4 or by treating the C'4,2a complex. Since both activity and stability of the enzyme are affected, one might postulate that two distinct groups in the CP2 portion are involved, one located in the active site, the other in the combining region. Alternatively, one could visualize the iodine effect to be caused by the modification of only one critical group which allosterically controls the active as well as the combining site. Further elucidation of the iodine effect will have to await the preparation of larger amounts of highly purified C'2 for chemical analyses, a task which is rendered difficult by the exceedingly low concentration of C'2 in serum. SUMMARY A method has been described for the chemical modification of human C'2 which results in a pronounced enhancement of its hemolytic activity and a marked increase in the stability of the intermediate complex EACqa,4,2a prepared with the modified C'2. Both effects are fully explained by the observed increase in activity and stability of the C'3 converting enzyme, C'4,2a, following its generation with modified C~2. Evidence has been presented in support of the hypothesis that the modification resulting from treatment of CI2 with a critical concentration of iodine consists of oxidation of one or more sulfhydryl group within the molecule. 
